Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
de Andrés, Clara
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. [electronic resource] - Journal of neuroimmunology Jan 2007 - 204-11 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0165-5728
10.1016/j.jneuroim.2006.09.012 doi
Adjuvants, Immunologic--therapeutic use
Adult
CD4-Positive T-Lymphocytes--metabolism
Cohort Studies
Female
Glucocorticoid-Induced TNFR-Related Protein
Humans
In Vitro Techniques
Interferon beta-1a
Interferon-beta--therapeutic use
Interleukin-2 Receptor alpha Subunit--metabolism
Longitudinal Studies
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting--blood
Receptors, Nerve Growth Factor--metabolism
Receptors, Tumor Necrosis Factor--metabolism
T-Lymphocyte Subsets--pathology
T-Lymphocytes, Regulatory--immunology
Treatment Outcome
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. [electronic resource] - Journal of neuroimmunology Jan 2007 - 204-11 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0165-5728
10.1016/j.jneuroim.2006.09.012 doi
Adjuvants, Immunologic--therapeutic use
Adult
CD4-Positive T-Lymphocytes--metabolism
Cohort Studies
Female
Glucocorticoid-Induced TNFR-Related Protein
Humans
In Vitro Techniques
Interferon beta-1a
Interferon-beta--therapeutic use
Interleukin-2 Receptor alpha Subunit--metabolism
Longitudinal Studies
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting--blood
Receptors, Nerve Growth Factor--metabolism
Receptors, Tumor Necrosis Factor--metabolism
T-Lymphocyte Subsets--pathology
T-Lymphocytes, Regulatory--immunology
Treatment Outcome